The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Combination Therapy Using Inhibitors Of Human Growth And Differentiation Factor 15 (Gdf-15) And Immune Checkpoint Blockers - EP3355919

The patent EP3355919 was granted to Julius Maximilians Universitt Wrzburg on Dec 7, 2022. The application was originally filed on Sep 30, 2016 under application number EP16778750A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3355919

JULIUS MAXIMILIANS UNIVERSITT WRZBURG
Application Number
EP16778750A
Filing Date
Sep 30, 2016
Status
Granted And Under Opposition
Nov 4, 2022
Publication Date
Dec 7, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PFIZERSep 6, 2023PFIZERADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2015EP56654
DESCRIPTIONWO2005099746
DESCRIPTIONWO2009021293
DESCRIPTIONWO2014049087
DESCRIPTIONWO2014100689
INTERNATIONAL-SEARCH-REPORTWO2015144855
OPPOSITIONUS2020055930
OPPOSITIONWO2014049087
OPPOSITIONWO2015144855

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents